S'abonner

Ankyrin repeat domain 1 regulates innate immune responses against herpes simplex virus 1: A potential role in eczema herpeticum - 06/06/18

Doi : 10.1016/j.jaci.2018.01.001 
Lianghua Bin, PhD a, b, Xiaozhao Li, MD, PhD a, , Brittany Richers, BS a, Joanne E. Streib, BA a, Jack W. Hu, MS c, Patricia Taylor, NP a, Donald Y.M. Leung, MD, PhD a, d,
a Department of Pediatrics, National Jewish Health, Denver, Colo 
b First Affiliated Hospital, Biomedical Translational Research Institute, the International Immunology Center and the Key Laboratory of Antibody Engineering of Guangdong Province, Jinan University, Guangzhou, China 
c Rho, Chapel Hill, NC 
d University of Colorado School of Medicine, Aurora, Colo 

Corresponding author: Donald Y. M. Leung, MD, PhD, Department of Pediatrics, National Jewish Health, 1400 Jackson St, Rm K926i, Denver, CO 80206.Department of PediatricsNational Jewish Health1400 Jackson StRm K926iDenverCO80206

Abstract

Background

Atopic dermatitis (AD) is a common inflammatory skin disease. A subset of patients with AD are susceptible to disseminated herpes simplex virus (HSV) infection, a complication termed eczema herpeticum (ADEH+). The immune mechanisms causing ADEH+ remain elusive. Using RNA sequencing, we recently found that ankyrin repeat domain 1 (ANKRD1) was significantly induced in human PBMCs upon HSV-1 stimulation, and its induction in patients with ADEH+ was significantly reduced compared with that seen in AD patients without a history of eczema herpeticum (ADEH−).

Objective

We sought to validate ANKRD1 gene expression in nonatopic (NA) subjects, patients with ADEH−, and patients with ADEH+ and to delineate the biological function of ANKRD1 and the signaling pathway or pathways involved.

Methods

Purification of human PBMCs, monocytes, B cells, dendritic cells, T cells, and natural killer cells; RNA extraction and quantitative RT-PCR; small interfering RNA technique; co-immunoprecipitation; and Western blot assays were used.

Results

ANKRD1 expression was significantly reduced in PBMCs from patients with ADEH+ after HSV-1 stimulation compared with PBMCs from patients with ADEH−. We found that the induction of ANKRD1 by HSV-1 and multiple pattern recognition receptor agonists are mediated by inflammatory cytokines. Silencing ANKRD1 gene expression in antigen-presenting cells led to increased viral load and reduced IFNB1 and IL29 production. Using co-immunoprecipitation methods, we demonstrated that ANKRD1 formed protein complexes with interferon regulatory factor (IRF) 3 and IRF7, which are important transcription factors regulating signaling transduction of pattern recognition receptors. Overexpression of ANKRD1 enhanced the IRF3-mediated signaling pathways.

Conclusion

ANKRD1 is involved in IRF3-mediated antiviral innate immune signaling pathways. Its reduced expression in patients with ADEH+ might contribute to the pathogenesis of ADEH+.

Le texte complet de cet article est disponible en PDF.

Key words : Herpes simplex virus, ankyrin repeat domain 1, innate immunity, atopic dermatitis, eczema herpeticum, interferon regulatory 3, nuclear factor κB1, IFN-β1, IL-29

Abbreviations used : AD, ADEH+, ADEH−, ANKRD1, APC, HA, HCV, HPV, HSV, IRF, MOI, NA, NF-κB, NK, Poly dA:dT, Poly I:C-LMW, PRR, qRT-PCR, siRNA, TLR


Plan


 Supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases through the Atopic Dermatitis Research Network (U19 AI117673). L.B. is also supported by National Natural Science Foundation of China (no. 81371716) and 111 project (B16021). The CTRC is supported in part by the Colorado Clinical and Translational Science Award/Colorado Clinical & Translational Sciences Institute grant UL1 RR025780 from National Center for Research Resources/National Institutes of Health (NIH) and UL1 TR0001082 from the NIH/National Center for Advancing Translational Sciences. Additionally, the authors wish to acknowledge the Edelstein Family Foundation for their generous support of our work.
 Disclosure of potential conflict of interest: P. Taylor and D. Y. M. Leung indicate that the work was supported by the National Institute of Allergy and Infectious Diseases/National Institute of Health–funded Atopic Dermatitis Research Network (1U19Al117673). The rest of the authors declare that they have no relevant conflicts of interest.


© 2018  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 141 - N° 6

P. 2085 - juin 2018 Retour au numéro
Article précédent Article précédent
  • Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures
  • Manel Essaidi-Laziosi, Francisco Brito, Sacha Benaoudia, Léna Royston, Valeria Cagno, Mélanie Fernandes-Rocha, Isabelle Piuz, Evgeny Zdobnov, Song Huang, Samuel Constant, Marc-Olivier Boldi, Laurent Kaiser, Caroline Tapparel
| Article suivant Article suivant
  • Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations
  • Patrick M. Brunner, Ariel Israel, Ning Zhang, Alexandra Leonard, Huei-Chi Wen, Thy Huynh, Gary Tran, Sarah Lyon, Giselle Rodriguez, Supriya Immaneni, Annette Wagner, Xiuzhong Zheng, Yeriel D. Estrada, Hui Xu, James G. Krueger, Amy S. Paller, Emma Guttman-Yassky

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.